OliX PharmaceuticalsInc - Asset Resilience Ratio

Latest as of March 2026: 52.23%

OliX PharmaceuticalsInc (226950) has an Asset Resilience Ratio of 52.23% as of March 2026. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See 226950 current assets to equity ratio to evaluate short-term liquidity relative to the company's equity base.

Liquid Assets

₩97.34 Billion

≈ $65.96 Million USD Cash + Short-term Investments

Total Assets

₩186.35 Billion

≈ $126.29 Million USD All company assets

Resilience Assessment

Very High

Financial Resilience Level

Asset Resilience Ratio Trend (2016–2025)

This chart shows how OliX PharmaceuticalsInc's Asset Resilience Ratio has changed over time. For the complete balance sheet picture, see OliX PharmaceuticalsInc (226950) total assets.

Liquid Assets Composition Over Time

This chart breaks down OliX PharmaceuticalsInc's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. Explore OliX PharmaceuticalsInc long-term investment intensity to see how much of total assets are deployed in long-term investments.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	₩0.00	0%
Short-term Investments	₩97.34 Billion	52.23%
Total Liquid Assets	₩97.34 Billion	52.23%

Asset Resilience Insights

Very High Liquidity: OliX PharmaceuticalsInc maintains exceptional liquid asset reserves at 52.23% of total assets.
This level provides strong protection against economic uncertainties but may indicate potential for more aggressive growth investments.
The company has significant short-term investments, indicating active treasury management.

OliX PharmaceuticalsInc Industry Peers by Asset Resilience Ratio

Compare OliX PharmaceuticalsInc's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
argenx NV ADR NASDAQ:ARGX	Biotechnology	15.95%
Madrigal Pharmaceuticals Inc NASDAQ:MDGL	Biotechnology	62.31%
Shanghai RAAS Blood Products Co Ltd Class A SHE:002252	Biotechnology	2.03%
Halozyme Therapeutics Inc NASDAQ:HALO	Biotechnology	12.71%
Tubize-Fin BR:TUB	Biotechnology	2.50%
Aurinia Pharmaceuticals Inc NASDAQ:AUPH	Biotechnology	33.23%
Nanobiotix NASDAQ:NBTX	Biotechnology	4.71%
Innovita Biological Technology Co. Ltd. A SHG:688253	Biotechnology	65.12%

Annual Asset Resilience Ratio for OliX PharmaceuticalsInc (2016–2025)

The table below shows the annual Asset Resilience Ratio data for OliX PharmaceuticalsInc.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2025-12-31	64.57%	₩126.15 Billion ≈ $85.49 Million	₩195.37 Billion ≈ $132.40 Million	+52.61pp
2024-12-31	11.96%	₩8.52 Billion ≈ $5.78 Million	₩71.25 Billion ≈ $48.28 Million	-1.59pp
2023-12-31	13.55%	₩13.93 Billion ≈ $9.44 Million	₩102.83 Billion ≈ $69.68 Million	-33.09pp
2022-12-31	46.64%	₩61.87 Billion ≈ $41.93 Million	₩132.65 Billion ≈ $89.90 Million	-10.77pp
2021-12-31	57.41%	₩49.76 Billion ≈ $33.72 Million	₩86.67 Billion ≈ $58.74 Million	-29.27pp
2020-12-31	86.68%	₩68.11 Billion ≈ $46.16 Million	₩78.58 Billion ≈ $53.25 Million	+42.54pp
2019-12-31	44.14%	₩19.95 Billion ≈ $13.52 Million	₩45.21 Billion ≈ $30.64 Million	-7.65pp
2018-12-31	51.79%	₩28.81 Billion ≈ $19.53 Million	₩55.64 Billion ≈ $37.70 Million	-0.51pp
2017-12-31	52.30%	₩11.32 Billion ≈ $7.67 Million	₩21.64 Billion ≈ $14.67 Million	-10.30pp
2016-12-31	62.60%	₩9.48 Billion ≈ $6.43 Million	₩15.15 Billion ≈ $10.27 Million	--

pp = percentage points

About OliX PharmaceuticalsInc

KQ:226950 Korea Biotechnology

Market Cap

$1.49 Billion

₩2.20 Trillion KRW

Market Cap Rank

#7259 Global

#183 in Korea

Share Price

₩108300.00

Change (1 day)

+8.19%

52-Week Range

₩81700.00 - ₩207000.00

All Time High

₩207000.00